| Sample | Title | Value | Rank |
|---|
| GSM303966 | SLE-7 #4 @12wks, asymptomatic (-2077090517) | 141.667 | 78 |
| GSM303972 | SLE-7 #3 @12wks, asymptomatic (-2077090523) | 110.183 | 73 |
| GSM303986 | SLE-7 #2 @12wks, asymptomatic (-2077090529) | 140.333 | 78 |
| GSM303991 | SLE-7 #1 @12wks, asymptomatic (-2077090535) | 123.32 | 75 |
| GSM303961 | SLE-7 #1 @36wks, asymptomatic on treatment with sirolimus (-2101366109) | 145.406 | 79 |
| GSM303979 | SLE-7 #3 @36wks, asymptomatic on treatment with sirolimus (-2101365196) | 137.703 | 77 |
| GSM303985 | SLE-7 #2 @36wks, asymptomatic on treatment with sirolimus (-2101365652) | 156.29 | 80 |
| GSM303971 | SLE-7 #2 @36wks, diseased/symptomatic (-2101366115) | 132.967 | 77 |
| GSM303973 | SLE-7 #1 @36wks, diseased/symptomatic (-2101366147) | 108.88 | 73 |
| GSM303980 | SLE-7 #3 @36wks, diseased/symptomatic (-2102085829) | 131.895 | 76 |
| GSM303962 | SLE-7 #3 @42wks, asymptomatic on treatment with sirolimus (-2101365164) | 132.929 | 77 |
| GSM303978 | SLE-7 #2 @42wks, asymptomatic on treatment with sirolimus (-2102085846) | 152.292 | 80 |
| GSM303982 | SLE-7 #1 @42wks, asymptomatic on treatment with sirolimus (-2101365170) | 161.358 | 81 |
| GSM303965 | SLE-7 #2 @42wks, diseased/symptomatic (-2102085823) | 145.064 | 78 |
| GSM303968 | SLE-7 #1 @42wks, diseased/symptomatic (-2101365185) | 148.732 | 79 |
| GSM303981 | SLE-7 #3 @42wks, diseased/symptomatic (-2101365176) | 132.32 | 76 |